NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation | Biotech Hunter

Enrollment

114

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions

Insomnia

Interventions

DRUG

V117957 tablets

V117957 tablets taken orally at bedtime

DRUG

Placebo

Tablets to match V117957

Trial Locations (17)

10019

Clinilabs Drug Development Corporation, New York

11235

SPRI Clinical Trials, Brooklyn

20815

Investigational Site, Chevy Chase

21061

Sleep Disorders Centers of the Mid Atlantic, Glen Burnie

30328

NeuroTrials Research Inc, Atlanta

33016

Innovative Clinical Research, Inc., Miami Lakes

33024

Research Centers of America, Hollywood

33157

Research Centers of America, LLC, Miami

33765

St. Francis Medical Institute, Clearwater

45212

CTI Clinical Research Center, Cincinnati

78628

Advanced Medical Trials, Georgetown

89104

Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas

91206

California Clinical Trials Medical Group, Glendale

92103

Artemis Institute for Clinical Research, San Diego

92503

Artemis Institute for Clinical Research, Riverside

92705

CITrials, Santa Ana

SDS Clinical Trials, Inc., Santa Ana